Open Access

Repression of metadherin inhibits biological behavior of prostate cancer cells and enhances their sensitivity to cisplatin

  • Authors:
    • Yong‑Bao Wei
    • Qiong Guo
    • Yun‑Liang Gao
    • Bin Yan
    • Zhao Wang
    • Jin‑Rui Yang
    • Wei Liu
  • View Affiliations

  • Published online on: February 16, 2015     https://doi.org/10.3892/mmr.2015.3357
  • Pages: 226-232
  • Copyright: © Wei et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY_NC 3.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Metadherin (MTDH), also known as astrocyte‑elevated gene‑1, was first cloned in 2002 and has been confirmed as an oncogene in numerous types of cancer by previous studies. Overexpression of MTDH has been observed in multiple types of cancer, including breast, esophageal, prostate, cervical and non‑small‑cell lung cancer, as well as neuroblastoma and hepatocellular carcinoma. However, at present, few investigations into MTDH‑associated prostate cancer have been performed. A previous study suggested that MTDH was expressed at higher levels in prostate cancer samples, compared with those of benign prostatic hyperplasia. The present study aimed to elucidate the effects of MTDH as an oncogene associated with the biological behavior of prostate cancer cells and chemotherapy‑sensitivity to cisplatin in vitro. It was demonstrated that the inhibition of MTDH expression promoted cell apoptosis, reduced cell viability and weakened the invasive ability of prostate cancer cells. In addition, the suppression of MTDH expression increased cell sensitivity to cisplatin. Furthermore, it was demonstrated that MTDH‑associated phosphoinositide 3‑kinase/Akt signaling pathways may be involved in mediating the biological behavior of prostate cancer.
View Figures
View References

Related Articles

Journal Cover

July-2015
Volume 12 Issue 1

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Wei YB, Guo Q, Gao YL, Yan B, Wang Z, Yang JR and Liu W: Repression of metadherin inhibits biological behavior of prostate cancer cells and enhances their sensitivity to cisplatin. Mol Med Rep 12: 226-232, 2015
APA
Wei, Y., Guo, Q., Gao, Y., Yan, B., Wang, Z., Yang, J., & Liu, W. (2015). Repression of metadherin inhibits biological behavior of prostate cancer cells and enhances their sensitivity to cisplatin. Molecular Medicine Reports, 12, 226-232. https://doi.org/10.3892/mmr.2015.3357
MLA
Wei, Y., Guo, Q., Gao, Y., Yan, B., Wang, Z., Yang, J., Liu, W."Repression of metadherin inhibits biological behavior of prostate cancer cells and enhances their sensitivity to cisplatin". Molecular Medicine Reports 12.1 (2015): 226-232.
Chicago
Wei, Y., Guo, Q., Gao, Y., Yan, B., Wang, Z., Yang, J., Liu, W."Repression of metadherin inhibits biological behavior of prostate cancer cells and enhances their sensitivity to cisplatin". Molecular Medicine Reports 12, no. 1 (2015): 226-232. https://doi.org/10.3892/mmr.2015.3357